Results for tag: "Tinzaparin"

Tinzaparin is a low molecular weight heparin (LMWH) anticoagulant used in the treatment of cardiovascular diseases. It is a type of anticoagulant that works by preventing the formation of blood clots. Tinzaparin is used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to prevent the formation of blood clots in patients undergoing certain types of surgery. It is also used to prevent stroke in patients with atrial fibrillation. Tinzaparin is administered by subcutaneous injection and is available in both generic and branded forms. The Tinzaparin market is a rapidly growing segment of the cardiovascular drugs market. It is expected to witness strong growth in the coming years, driven by the increasing prevalence of cardiovascular diseases, the growing demand for anticoagulants, and the increasing availability of generic versions of Tinzaparin. Some of the major companies operating in the Tinzaparin market include Sanofi, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Novartis, Bayer, and Daiichi Sankyo. Show Less Read more